0000899243-20-034573.txt : 20201218
0000899243-20-034573.hdr.sgml : 20201218
20201218212501
ACCESSION NUMBER: 0000899243-20-034573
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20201218
FILED AS OF DATE: 20201218
DATE AS OF CHANGE: 20201218
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: AMGEN INC
CENTRAL INDEX KEY: 0000318154
STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-37686
FILM NUMBER: 201402180
BUSINESS ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
BUSINESS PHONE: (805)447-1000
MAIL ADDRESS:
STREET 1: ONE AMGEN CENTER DRIVE
CITY: THOUSAND OAKS
STATE: CA
ZIP: 91320
FORMER NAME:
FORMER CONFORMED NAME: AMGEN
DATE OF NAME CHANGE: 19870305
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BeiGene, Ltd.
CENTRAL INDEX KEY: 0001651308
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 981209416
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
STREET 2: 94 SOLARIS AVENUE, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
BUSINESS PHONE: 13459494123
MAIL ADDRESS:
STREET 1: C/O MOURANT GOVERNANCE SERVICES (CAYMAN)
STREET 2: 94 SOLARIS AVENUE, CAMANA BAY
CITY: GRAND CAYMAN
STATE: E9
ZIP: KY1-1108
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2020-12-18
0
0001651308
BeiGene, Ltd.
BGNE
0000318154
AMGEN INC
ONE AMGEN CENTER DRIVE
THOUSAND OAKS
CA
91320
0
0
1
0
American Depositary Shares
2020-12-18
4
A
0
25762
260.9465
A
18778273
D
This transaction was made pursuant to a previously adopted plan complying with Rule 10b5-1.
The price reported is an average price. These American Depositary Shares ("ADSs") were purchased at prices ranging from $256.72 to $264.92 per ADS. Full information regarding the number of ADSs purchased at each separate price is available upon request by the SEC staff, the issuer or a security holder of the issuer.
As each ADS represents 13 Ordinary Shares of the Issuer, the reported securities represent 244,117,549 Ordinary Shares.
By: /s/ Andrea A. Robinson, Associate General Counsel and Assistant Secretary
2020-12-18